GlassScriptPhysician profile
Emily Wharton
NPI 1487359659
$1,092.82
in general payments reported to CMS, 2019-2025
17 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $399 · 2024: $470 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,076 · Education: $16.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.47 |
| Education | $16.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $224.88 | 2023-2024 | Wegovy |
| Abbvie INC. | $153.02 | 2023-2024 | |
| Astellas Pharma US INC | $141.69 | 2024 | Veozah |
| Radius Health, INC. | $119.69 | 2025 | Tymlos |
| Sumitomo Pharma America, INC. | $68.66 | 2023-2024 | Myfembree |
| Exact Sciences Corporation | $61.84 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Philips North America LLC | $49.35 | 2024-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Ck6) Holter |
| Dexcom, INC. | $45.54 | 2024-2025 | Dexcom G6 Transmitter |
| Organon LLC | $35.22 | 2023 | Nexplanon |
| Coopersurgical, INC. | $32.82 | 2024 | Paragard T 380a |
| Shield Therapeutics INC | $29.94 | 2023 | Accrufer |
| Currax Pharmaceuticals LLC | $27.67 | 2023 | Contrave, Onzetra Xsail |
| Amgen INC. | $26.04 | 2024 | Evenity, Prolia |
| Mayne Pharma Commercial LLC | $23.20 | 2023 | |
| Lilly USA, LLC | $20.97 | 2024 | Zepbound |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $16.92 | 2025 | Cequr Simplicity |
| Mycovia Pharmaceuticals, INC. | $15.37 | 2023 | Vivjoa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Wharton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.